cyclopentane has been researched along with B-Cell Lymphoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abedi, M; Chen, M; Khuat, LT; Murphy, WJ; Pai, CS | 1 |
| Altboum, I; Fingrut, O; Flescher, E; Goldin, N; Reischer, D; Rotem, R; Zan-Bar, I | 1 |
| Chiocchia, G; Fournier, C; Lotteau, V; Manoury-Schwartz, B | 1 |
| Chakrabarti, D; Ghosh, SK | 1 |
| Hofmann, WJ; Koch, N; Moldenhauer, G; Möller, P | 1 |
5 other study(ies) available for cyclopentane and B-Cell Lymphoma
| Article | Year |
|---|---|
Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice.
Topics: Animals; Antigen-Presenting Cells; Cyclopentanes; Enzyme Inhibitors; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Lymphoma, B-Cell; Mice; Pyrimidines; Scleroderma, Systemic; T-Lymphocytes; Time Factors; Transplantation, Homologous; Ubiquitin-Activating Enzymes | 2017 |
Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells.
Topics: Acetates; Adenosine Triphosphate; Antibiotics, Antineoplastic; Bleomycin; Cell Survival; Clone Cells; Cyclopentanes; Deoxyglucose; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Immunoblotting; Lymphoma, B-Cell; Mutation; Oligomycins; Oxylipins; Plant Growth Regulators; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Zinostatin | 2005 |
Selective increased presentation of type II collagen by leupeptin.
Topics: Animals; Antigen Presentation; Antigen-Presenting Cells; Antigens, Differentiation, B-Lymphocyte; Brefeldin A; Collagen; Cyclopentanes; Dimerization; Epitopes; Histocompatibility Antigens Class II; Immunophenotyping; Leupeptins; Lymphoma, B-Cell; Mice; Mice, Inbred DBA; Protease Inhibitors; Protein Synthesis Inhibitors; Sodium Dodecyl Sulfate; Tumor Cells, Cultured | 1997 |
Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. III. MHC class I-restricted CTL recognizes the processed form(s) of idiotype.
Topics: Animals; Antigen-Presenting Cells; Brefeldin A; Chloroquine; Cyclopentanes; Histocompatibility Antigens Class I; Immunoglobulin Idiotypes; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Receptors, Antigen, B-Cell; Receptors, Antigen, T-Cell; T-Lymphocytes, Cytotoxic | 1992 |
Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74).
Topics: Antigens, Differentiation, B-Lymphocyte; Antigens, Surface; Biological Transport; Brefeldin A; Chloroquine; Cyclopentanes; Histocompatibility Antigens Class II; Humans; Lymphoma, B-Cell; Microscopy, Immunoelectron; Tumor Cells, Cultured | 1991 |